Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA,
WHO, and other public sources. It is an independent information service, not a medical provider, and
not a substitute for professional medical advice or your local public health department's own guidance.
Policy version 2026-07-21, effective July 21, 2026.
If you are experiencing a medical emergency, call your local emergency services immediately. For food
recalls and disease investigations, always refer to the official CDC, FDA, USDA, WHO, or your local
public health authority for the most current information.
DAISO CALIFORNIA WAREHOUSE Recall: Label warns for fish but does not specify anchovy or sardine; Canada lists clams in ingredients but not in contains statement.
🇺🇸 United States
TerminatedClass III
Company
DAISO CALIFORNIA WAREHOUSE
Product
Daisho Kimchi hotpot soup 750g UPC: 4904621042653
Recall date
March 3, 2023
Terminated
May 3, 2024
Source
FDA
Reason for recall
Label warns for fish but does not specify anchovy or sardine; Canada lists clams in ingredients but not in contains statement.
- Recall initiated
- Reported by source
- Recall terminated
Recalled products
Product description
UPC
Quantity
Lot / code information
Daisho Kimchi hotpot soup 750g UPC: 4904621042653
4904621042653
4,078 units
No code on package
Distribution
Products were distributed to customer retail locations in California
Texas
Nevada
New York
New Jersey
Washington
and British Columbia Canada.
Official source record
Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-0868-2023
Event ID
91843
Status
Terminated
Classification
Class III
Company
DAISO CALIFORNIA WAREHOUSE
Product description
Daisho Kimchi hotpot soup 750g UPC: 4904621042653
Quantity
4,078 units
Reason
Label warns for fish but does not specify anchovy or sardine; Canada lists clams in ingredients but not in contains statement.
Recall initiation date
March 3, 2023
Report date
May 17, 2023
Classification date
Not published in this source record
Termination date
May 3, 2024
Distribution pattern
Products were distributed to customer retail locations in California, Texas, Nevada, New York, New Jersey, Washington, and British Columbia Canada.
UPC, lot, and code information
UPC 4904621042653; No code on package
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date
Other products recalled under this same event
This recall shares FDA event ID 91843 with 10 other product
entries in Public Health Trace.
FDA Recall🇺🇸 United StatesTerminatedHistorical recordClass III
DAISO CALIFORNIA WAREHOUSE
Product
Fujiya Country Ma'am Vanilla & Cocoa 19 sheets UPC: 4902555…
View raw source data
-- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class III mean?
A situation in which use of or exposure to a product is not likely to cause adverse health consequences.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
Where can I find more official information?
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company
or product is unsafe beyond what the official source has published.
Read the full medical disclaimer.